Education
About Us
Working with TipRanks
Follow Us
IDEAYA Biosciences (IDYA)
NASDAQ:IDYA
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 218.71M | $ 7.00M | $ 23.39M | $ 50.93M | $ 27.94M |
| Gross Profit | $ 214.12M | $ 3.17M | $ 19.38M | $ 48.83M | $ 26.22M |
| Operating Income | $ -159.31M | $ -326.98M | $ -134.43M | $ -62.50M | $ -50.27M |
| EBITDA | $ -154.72M | $ -270.64M | $ -108.95M | $ -56.55M | $ -48.04M |
| Net Income | $ -113.70M | $ -274.48M | $ -112.96M | $ -58.66M | $ -49.76M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 639.39M | $ 676.32M | $ 525.11M | $ 364.83M | $ 246.77M |
| Total Assets | $ 1.11B | $ 1.12B | $ 649.32M | $ 387.97M | $ 381.35M |
| Total Debt | $ 27.91M | $ 19.17M | $ 2.87M | $ 3.48M | $ 5.18M |
| Net Debt | $ -84.91M | $ -65.21M | $ -154.15M | $ -65.15M | $ -86.86M |
| Total Liabilities | $ 86.39M | $ 64.94M | $ 28.23M | $ 38.51M | $ 79.83M |
| Stockholders' Equity | $ 1.02B | $ 1.06B | $ 621.09M | $ 349.45M | $ 301.51M |
| Cash Flow | |||||
| Free Cash Flow | $ -73.47M | $ -251.44M | $ -117.59M | $ -90.62M | $ -58.42M |
| Operating Cash Flow | $ -71.10M | $ -247.58M | $ -115.22M | $ -87.17M | $ -55.78M |
| Investing Cash Flow | $ 69.98M | $ -502.56M | $ -158.46M | $ -33.40M | $ -69.67M |
| Financing Cash Flow | $ 29.78M | $ 677.55M | $ 362.72M | $ 97.17M | $ 145.45M |